NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
2.520
-0.060 (-2.33%)
At close: Aug 28, 2025, 4:00 PM
2.530
+0.010 (0.40%)
After-hours: Aug 28, 2025, 7:53 PM EDT

NRx Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
Net Income
-33.79-25.13-30.15-39.75-93.06-51.78
Upgrade
Depreciation & Amortization
00.010.01000
Upgrade
Other Amortization
1.250.9---0.02
Upgrade
Stock-Based Compensation
0.410.520.393.637.790.73
Upgrade
Other Operating Activities
20.787.772.94-4.3352.4745.31
Upgrade
Change in Accounts Receivable
----0.83-0.83
Upgrade
Change in Accounts Payable
-9.93-5.222.66-1.61-0.021.18
Upgrade
Change in Other Net Operating Assets
9.3710.512.512.31-5.713.1
Upgrade
Operating Cash Flow
-11.91-10.64-21.66-39.76-37.7-2.27
Upgrade
Capital Expenditures
---0-0.01-0.01-0
Upgrade
Investing Cash Flow
---0-0.01-0.01-0
Upgrade
Short-Term Debt Issued
-1.050.94---
Upgrade
Long-Term Debt Issued
-6.03-10.02-0.62
Upgrade
Total Debt Issued
12.537.080.9410.02-0.62
Upgrade
Short-Term Debt Repaid
--0.73-0.94--0.18-
Upgrade
Long-Term Debt Repaid
--7.85-3.09-0.52-1.1-
Upgrade
Total Debt Repaid
-6.81-8.58-4.04-0.52-1.28-
Upgrade
Net Debt Issued (Repaid)
5.72-1.5-3.099.5-1.280.62
Upgrade
Issuance of Common Stock
3.475.918.1222.7153.682.58
Upgrade
Other Financing Activities
3.733.07--11.05-
Upgrade
Financing Cash Flow
12.927.496.232.2163.463.25
Upgrade
Net Cash Flow
1.01-3.15-15.46-7.5525.750.98
Upgrade
Free Cash Flow
-11.91-10.64-21.66-39.77-37.71-2.27
Upgrade
Free Cash Flow Per Share
-0.83-1.00-2.86-6.05-8.04-0.66
Upgrade
Cash Interest Paid
-0.370.89---
Upgrade
Levered Free Cash Flow
8.730.13-11.47-28.24-89.836.12
Upgrade
Unlevered Free Cash Flow
7.48-0.63-11.4-28.24-89.7936.14
Upgrade
Change in Working Capital
-0.565.295.160.7-4.93.45
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q